VTR - Ventas, Inc.
NYSE
->
Real Estate
->
REIT—Healthcare Facilities
Chicago,
United States
Type: Equity
VTR price evolution
VTR
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $563.46 | $491.75 | $210.35 | $195.28 |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $508.79 | $433.94 | $138.65 | $145.36 |
| Long term investments | ||||
| Property, plant & equipment | $22375.14 | $22695.78 | $23140.04 | $22106.32 |
| Goodwill & intangible assets | $1045.18 | $1044.54 | $1045.15 | $1044.7 |
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $24725.43 | $24966.61 | $25070.86 | $23994.17 |
| Current liabilities | ||||
| Accounts payable | $1041.62 | $1090.03 | $1069.59 | $1007.44 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $1353.75 | $1407.38 | $1383.35 | $1290.89 |
| Long term debt | $13490.9 | $13388.5 | $13354.74 | $12342.51 |
| Total noncurrent liabilities | ||||
| Total debt | $13685.63 | $13586.16 | $13555.71 | $12532.42 |
| Total liabilities | $14878.39 | $14827.12 | $14770.75 | $13669.68 |
| Shareholders' equity | ||||
| Retained earnings | -$6213.8 | -$5941.3 | -$5688.5 | -$5611.07 |
| Other shareholder equity | -$35.76 | -$6.18 | -$14.55 | -$40.47 |
| Total shareholder equity | $9488.06 | $9817.56 | $9968.38 | $9996.99 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $563.46 | $170.75 | $196.6 | $451.64 |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $508.79 | $122.56 | $149.72 | $688.04 |
| Long term investments | $844.83 | |||
| Property, plant & equipment | $22375.14 | $21160.45 | $22870.43 | $21599.29 |
| Goodwill & intangible assets | $1045.18 | $1044.41 | $1046.14 | $1051.65 |
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $24725.43 | $24157.84 | $24717.79 | $23929.4 |
| Current liabilities | ||||
| Accounts payable | $1041.62 | $1031.69 | $1090.25 | $1133.07 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $1353.75 | $1332.67 | $1394.09 | $1128.44 |
| Long term debt | $13490.9 | $12296.78 | $12027.54 | $11895.41 |
| Total noncurrent liabilities | ||||
| Total debt | $13685.63 | $12487.22 | $12224.78 | $12105.33 |
| Total liabilities | $14878.39 | $13740.22 | $13491.74 | $13415.72 |
| Shareholders' equity | ||||
| Retained earnings | -$6213.8 | -$5449.39 | -$4679.89 | -$4030.38 |
| Other shareholder equity | -$35.76 | $227.85 | -$64.52 | -$54.35 |
| Total shareholder equity | $9488.06 | $10152.97 | $10854.39 | $10180.17 |
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1164.39 | $1106.36 | $1077.24 | |
| Cost of revenue | $669.41 | $624.25 | $609.64 | |
| Gross Profit | $494.99 | $482.1 | $467.61 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $36.38 | $34.4 | $44.8 | |
| Total operating expenses | $452.98 | $283.01 | $328 | |
| Operating income | $42 | $199.1 | $139.61 | |
| Income from continuing operations | ||||
| EBIT | $68.73 | $236.94 | $142.79 | |
| Income tax expense | $4.7 | -$9.77 | -$2.8 | |
| Interest expense | $154.85 | $143.26 | $128.07 | |
| Net income | ||||
| Net income | -$90.82 | $103.45 | $17.52 | |
| Income (for common shares) | -$90.82 | $103.45 | $17.52 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4497.83 | $4129.19 | $3828.01 | $3795.36 |
| Cost of revenue | $2561.25 | $2282.92 | $2088.5 | $1939.76 |
| Gross Profit | $1936.58 | $1846.28 | $1739.51 | $1855.6 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $148.88 | $144.87 | $129.76 | $130.16 |
| Total operating expenses | $1484.15 | $1472.27 | $1402.51 | $1294.68 |
| Operating income | $452.43 | $374 | $337 | $560.92 |
| Income from continuing operations | ||||
| EBIT | $523.6 | $403.18 | $493.92 | $812.16 |
| Income tax expense | -$9.54 | -$16.93 | $4.83 | -$96.53 |
| Interest expense | $574.11 | $467.56 | $440.09 | $469.54 |
| Net income | ||||
| Net income | -$40.97 | -$47.45 | $49.01 | $439.15 |
| Income (for common shares) | -$40.97 | -$47.45 | $49.01 | $439.15 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$90.82 | -$71.12 | $103.45 | $17.52 |
| Operating activities | ||||
| Depreciation | $435.28 | $370.38 | $304.69 | $282.12 |
| Business acquisitions & disposals | -$32.53 | $40.93 | $21.6 | -$35.79 |
| Stock-based compensation | $5.69 | $4.91 | $5.33 | $15.06 |
| Total cash flows from operations | $279.08 | $286.14 | $311.83 | $242.82 |
| Investing activities | ||||
| Capital expenditures | -$12.6 | -$59.69 | -$111.41 | -$66.24 |
| Investments | -$1.27 | -$0.08 | -$0.83 | $44.06 |
| Total cash flows from investing | -$43.28 | -$13.78 | -$71.33 | -$56.28 |
| Financing activities | ||||
| Dividends paid | -$181.32 | -$180.53 | -$180.28 | -$181.42 |
| Sale and purchase of stock | $83.45 | $25.01 | $1.74 | |
| Net borrowings | $20.09 | $104.71 | -$59.56 | $32.5 |
| Total cash flows from financing | -$165.46 | $9.79 | -$225.98 | -$162.11 |
| Effect of exchange rate | $1.36 | -$0.76 | $0.54 | $0.11 |
| Change in cash and equivalents | $70.35 | $282.15 | $14.52 | $24.43 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$40.97 | -$47.45 | $49.01 | $439.15 |
| Operating activities | ||||
| Depreciation | $1392.46 | $1197.8 | $1197.4 | $1109.76 |
| Business acquisitions & disposals | -$5.8 | -$55.34 | -$111.44 | -$286.82 |
| Stock-based compensation | $30.99 | $30.71 | $31.97 | $21.49 |
| Total cash flows from operations | $1119.87 | $1120.16 | $1026.12 | $1450.18 |
| Investing activities | ||||
| Capital expenditures | -$249.94 | -$787.77 | -$961.58 | $437.06 |
| Investments | $41.88 | -$29.81 | $347.6 | $3.85 |
| Total cash flows from investing | -$184.66 | -$859.22 | -$724.14 | $154.29 |
| Financing activities | ||||
| Dividends paid | -$723.56 | -$720.32 | -$686.89 | -$928.81 |
| Sale and purchase of stock | $110.19 | $8.69 | $625.61 | $70.47 |
| Net borrowings | $97.75 | $468.8 | -$447.95 | -$409.01 |
| Total cash flows from financing | -$543.75 | -$283.93 | -$558.47 | -$1300.02 |
| Effect of exchange rate | $1.26 | -$2.87 | $1.45 | $1.09 |
| Change in cash and equivalents | $391.46 | -$22.98 | -$256.49 | $304.45 |
News
|
Is it Wise to Retain Ventas (VTR) Stock in Your Portfolio?
Zacks via Yahoo Finance
12 Apr 2024
|
|
Ventas (VTR) Sees Strong Demand & Occupancy Growth in 2024
Zacks via Yahoo Finance
3 Apr 2024
|
|
Ventas Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance
28 Mar 2024
|
|
Invest Like Bill Gates with These REITs
Benzinga via Yahoo Finance
29 Feb 2024
|
|
Wall Street's Most Accurate Analysts' Views On 3 Real Estate Stocks With Over 4% Dividend Yields -...
Benzinga
21 Feb 2024
|
|
Pfizer's Expansion Sparks Boom for these Healthcare REITs
Benzinga via Yahoo Finance
16 Feb 2024
|
|
Ventas, Inc. (NYSE:VTR) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance
16 Feb 2024
|
|
Digital Realty's (DLR) Q4 FFO & Revenues Miss Estimates
Zacks via Yahoo Finance
16 Feb 2024
|
|
Decoding Ventas Inc (VTR): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance
15 Feb 2024
|
|
Healthcare REIT Ventas reports rise in Q4 FFO By Reuters
Investing.com
14 Feb 2024
|
Fundamentals
| Market cap | $17.54B |
|---|---|
| Enterprise value | $30.66B |
| Shares outstanding | 402.10M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 10.74% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 1.84 |
| Book/Share | 23.69 |
| Cash/Share | 1.40 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.57 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.38 |
| Quick ratio | 0.38 |